Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

43.97
Delayed Data
As of Aug 27
 +0.54 / +1.24%
Today’s Change
22.25
Today|||52-Week Range
52.10
+38.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues158.0M131.2M143.1M214.2M
 
 
 
 
 
Cost of Goods Sold65.3M60.9M73.4M109.1M
 
 
 
 
 
Depreciation And Amortization8.2M9.5M10.4M20.3M
 
 
 
 
 
 
Operating ExpensesGross Income84.4M60.8M59.2M84.9M
 
 
 
 
 
General Expenses57.9M59.3M56.1M65.3M
 
 
 
 
 
Research And Development19.0M17.1M15.0M17.0M
 
 
 
 
 
Total Operating Expenses131.4M129.7M140.0M194.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income26.6M1.5M3.1M19.5M
 
 
 
 
 
Extraordinary Charge-1.1M-4.3M-10.0M-18.4M
 
 
 
 
 
Interest Expense On Debt--0.004.0M7.0M
 
 
 
Other Expenses-17.0K4.1M-166.0K961.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income25.9M1.7M-10.7M-4.5M
 
 
 
 
 
Income Taxes-10.1M-1.5M-4.4M-2.7M
 
 
 
 
 
Net Income15.7M120.0K-6.3M-1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.3M68.7M69.0M69.3M
 
 
 
 
 
Shares To Calculate EPS Diluted70.7M71.0M69.0M69.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.22$0.00-$0.09-$0.03
 
 
 
 
EPS Diluted$0.22$0.00-$0.09-$0.03